{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T18:49:00Z","timestamp":1771267740620,"version":"3.50.1"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["POCI-01-02B7-FEDER-053456, BIOBLOCKCOVID"],"award-info":[{"award-number":["POCI-01-02B7-FEDER-053456, BIOBLOCKCOVID"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["RESEARCH4COVID, Grants 104, 112, 418"],"award-info":[{"award-number":["RESEARCH4COVID, Grants 104, 112, 418"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["REF UID\/BIM\/04293\/2019"],"award-info":[{"award-number":["REF UID\/BIM\/04293\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>In late 2019, COVID-19 emerged in Wuhan, China. Currently, it is an ongoing global health threat stressing the need for therapeutic compounds. Linking the virus life cycle and its interaction with cell receptors and internal cellular machinery is key to developing therapies based on the control of infectivity and inflammation. In this framework, we evaluate the combination of cannabidiol (CBD), as an anti-inflammatory molecule, and terpenes, by their anti-microbiological properties, in reducing SARS-CoV-2 infectivity. Our group settled six formulations combining CBD and terpenes purified from <jats:italic>Cannabis sativa<\/jats:italic> L, <jats:italic>Origanum vulgare<\/jats:italic>, and <jats:italic>Thymus mastichina<\/jats:italic>. The formulations were analyzed by HPLC and GC-MS and evaluated for virucide and antiviral potential by <jats:italic>in vitro<\/jats:italic> studies in alveolar basal epithelial, colon, kidney, and keratinocyte human cell lines.<\/jats:p><jats:sec><jats:title>Conclusions and Impact<\/jats:title><jats:p>We demonstrate the virucide effectiveness of CBD and terpene-based formulations. F2TC reduces the infectivity by 17%, 24%, and 99% for CaCo-2, HaCat, and A549, respectively, and F1TC by 43%, 37%, and 29% for Hek293T, HaCaT, and Caco-2, respectively. To the best of our knowledge, this is the first approach that tackles the combination of CBD with a specific group of terpenes against SARS-CoV-2 in different cell lines. The differential effectiveness of formulations according to the cell line can be relevant to understanding the pattern of virus infectivity and the host inflammation response, and lead to new therapeutic strategies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.841459","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T06:53:02Z","timestamp":1644907982000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Cannabidiol and Terpene Formulation Reducing SARS-CoV-2 Infectivity Tackling a Therapeutic Strategy"],"prefix":"10.3389","volume":"13","author":[{"given":"Susana","family":"Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Barata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adilia","family":"Charmier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzilaine","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo M.","family":"Melosini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick J.","family":"Pais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 P.","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Catarina","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Baylina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25489","article-title":"Systematic Review of the Efficacy and Safety of Antiretroviral Drugs Against SARS, MERS or COVID-19: Initial Assessment","volume":"23","author":"Ford","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/plants9060800","article-title":"Aromatic Herbs, Medicinal Plant-Derived Essential Oils, and Phytochemical Extracts as Potential Therapies for Coronaviruses: Future Perspectives","volume":"9","author":"Boukhatem","year":"2020","journal-title":"Plants (Basel)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020335","article-title":"SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries","volume":"8","author":"Elshabrawy","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24213961","article-title":"Medically Useful Plant Terpenoids: Biosynthesis, Occurrence, and Mechanism of Action","volume":"24","author":"Bergman","year":"2019","journal-title":"Molecules"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1177\/1934578X1601100946","article-title":"Terpenoids With Special Pharmacological Significance: A Review","volume":"11","author":"Jaeger","year":"2016","journal-title":"Nat Prod Commun"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.200890045","article-title":"Phytochemical Analysis and In Vitro Antiviral Activities of the Essential Oils of Seven Lebanon Species","volume":"5","author":"Loizzo","year":"2008","journal-title":"Chem Biodivers"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1078\/094471103322331467","article-title":"Virucidal Effect of Peppermint Oil on the Enveloped Viruses Herpes Simplex Virus Type 1 and Type 2 In Vitro","volume":"10","author":"Schuhmacher","year":"2003","journal-title":"Phytomedicine"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-020-00744-0","article-title":"COVID-19 and Therapy With Essential Oils Having Antiviral, Anti-Inflammatory, and Immunomodulatory Properties","volume":"28","author":"Asif","year":"2020","journal-title":"Inflammopharmacology"},{"key":"B9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/9781444318876.ch4","article-title":"Plant-Microbe Interaction and Secondary Metabolites With Antiviral, Antibacterial and Antifungal Properties","volume-title":"Functions and Biotechnology of Plant Secondary Metabolites","author":"Reichling","year":"2010"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2017.1389369","article-title":"Effects of Cannabinoid Receptor Type 2 in Respiratory Syncytial Virus Infection in Human Subjects and Mice","volume":"9","author":"Tahamtan","year":"2018","journal-title":"Virulence"},{"key":"B11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jneuroim.2004.10.003","article-title":"The Nonpsychoactive Component of Marijuana Cannabidiol Modulates Chemotaxis and IL-10 and IL-12 Production of Murine Macrophages Both In Vivo and In Vitro","volume":"159","author":"Sacerdote","year":"2005","journal-title":"J Neuroimmunol"},{"key":"B12","first-page":"1138","article-title":"Effective Antiviral Activity of Essential Oils and Their Characteristic Terpenes Against Coronaviruses: An Update","volume":"8","author":"Nadjib","year":"2020","journal-title":"J Pharmacol Clin Toxicol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/biom10081139","article-title":"Immunomodulatory Activities of Selected Essential Oils","volume":"10","author":"Sandner","year":"2020","journal-title":"Biomolecules"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1053\/rmed.2003.1432","article-title":"Anti-Inflammatory Activity of 1.8-Cineol (Eucalyptol) in Bronchial Asthma: A Double-Blind Placebo-Controlled Trial","volume":"97","author":"Juergens","year":"2003","journal-title":"Respir Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01279-0","article-title":"New Perspectives for Mucolytic, Anti-Inflammatory and Adjunctive Therapy With 1,8-Cineole in COPD and Asthma: Review on the New Therapeutic Approach","volume":"37","author":"Juergens","year":"2020","journal-title":"Adv Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00139","article-title":"Current Antivirals and Novel Botanical Molecules Interfering With Herpes Simplex Virus Infection","volume":"11","author":"\u00c1lvarez","year":"2020","journal-title":"Front Microbiol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1012523","article-title":"Attenuation of HIV-1 Replication in Macrophages by Cannabinoid Receptor 2 Agonists","volume":"93","author":"Ramirez","year":"2013","journal-title":"J Leukoc Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1021\/jf049859g","article-title":"In Vitro Antioxidant, Antimicrobial, and Antiviral Activities of the Essential Oil and Various Extracts From Herbal Parts and Callus Cultures of Origanum Acutidens","volume":"52","author":"S\u00f6kmen","year":"2004","journal-title":"J Agric Food Chem"},{"key":"B19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1023\/A:1019630327576","article-title":"Chemical Composition and Biological Activity of the Essential Oil From Artemisia Glabella","volume":"36","author":"Seidakhmetova","year":"2002","journal-title":"Pharma Chem J"},{"key":"B20","article-title":"Antiviral Activity of Australian Tea Tree Oil and Eucalyptus Oil Against Herpes Simplex Virus in Cell Culture","volume":"56","author":"Schnitzler","year":"2001","journal-title":"Pharmazie"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.1348","article-title":"Chemical and Biological Evaluation of the Essential Oils of Different Melaleuca Species","volume":"18","author":"Farag","year":"2004","journal-title":"Phytother Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1021\/jm070295s","article-title":"Specific Plant Terpenoids and Lignoids Possess Potent Antiviral Activities Against Severe Acute Respiratory Syndrome Coronavirus","volume":"50","author":"Wen","year":"2007","journal-title":"J Med Chem"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/biom11010074","article-title":"Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors From Molecular Modeling Studies","volume":"11","author":"Diniz","year":"2021","journal-title":"Biomolecules"},{"key":"B24","article-title":"The Biotechnology of Oregano (Origanum Sp. And Lippia Sp.)","volume-title":"Medicinal and Aromatic Plants-Industrial Profiles, Oregano. The Genera Origanum and Lippia","author":"Kintzios","year":"2002"},{"key":"B25","doi-asserted-by":"crossref","first-page":"e4239118504","DOI":"10.33448\/rsd-v9i11.8504","article-title":"Organic Management vs. Conventional Management Influence the Antimicrobial Activity of Essential Oils of Origanum Vulgare L","volume":"9","author":"Pereira","year":"2020","journal-title":"Research Soc Dev"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.rvsc.2021.04.024","article-title":"Virucidal and Antiviral Effects of Thymus Vulgaris Essential Oil on Feline Coronavirus","volume":"137","author":"Catella","year":"2021","journal-title":"Res Vet Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01238","article-title":"Taming THC: Potential Cannabis Synergy and Phytocannabinoid-Terpenoid Entourage Effects","volume":"163","author":"Russo","year":"2011","journal-title":"Br J Pharmacol"},{"key":"B28","article-title":"Essential Oil of Cannabis Sativa L. Strains","volume":"4","author":"Mediavilla","year":"1997","journal-title":"J Int Hemp Assoc"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2005.09.011","article-title":"Chemical Constituents of Marijuana: The Complex Mixture of Natural Cannabinoids","volume":"78","author":"Elsohly","year":"2005","journal-title":"Life Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25245792","article-title":"The Cannabis Terpenes","volume":"25","author":"Sommano","year":"2020","journal-title":"Molecules"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1780","article-title":"Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents","volume":"36","author":"Fasinu","year":"2016","journal-title":"Pharmacotherapy"},{"key":"B32","article-title":"Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting","volume":"42","author":"Bridgeman","year":"2017","journal-title":"P T"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2015.01.059","article-title":"Cannabidiol (CBD) and Its Analogs: A Review of Their Effects on Inflammation","volume":"23","author":"Burstein","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-21737-2_8","article-title":"Pharmacology of Medical Cannabis","volume":"1162","author":"Amin","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of Cannabinoids and Cannabinoid-Enriched Cannabis Extracts on TRP Channels and Endocannabinoid Metabolic Enzymes","volume":"163","author":"De Petrocellis","year":"2011","journal-title":"Br J Pharmacol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2021.102047","article-title":"The Anti-Inflammatory Effects of Cannabidiol and Cannabigerol Alone, and in Combination","volume":"69","author":"Robaina Cabrera","year":"2021","journal-title":"Pulm Pharmacol Ther"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21145064","article-title":"Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products","volume":"21","author":"An","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System","volume":"19","author":"Zou","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2018.12.026","article-title":"Progress in Brain Cannabinoid CB2 Receptor Research: From Genes to Behavior","volume":"98","author":"Jordan","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/741303","article-title":"Cannabinoid Receptor 2 Protects Against Acute Experimental Sepsis in Mice","volume":"2013","author":"Gui","year":"2013","journal-title":"Mediators Inflamm"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21113809","article-title":"Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection","volume":"21","author":"Rossi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024793","article-title":"Oral Cannabinoids in People Living With HIV on Effective Antiretroviral Therapy: CTN PT028-Study Protocol for a Pilot Randomised Trial to Assess Safety, Tolerability and Effect on Immune Activation","volume":"9","author":"Costiniuk","year":"2019","journal-title":"BMJ Open"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfs315","article-title":"\u03949-Tetrahydrocannabinol Impairs the Inflammatory Response to Influenza Infection: Role of Antigen-Presenting Cells and the Cannabinoid Receptors 1 and 2","volume":"131","author":"Karmaus","year":"2013","journal-title":"Toxicol Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0907618","article-title":"Targeted Deletion of Cannabinoid Receptors CB1 and CB2 Produced Enhanced Inflammatory Responses to Influenza A\/PR\/8\/34 in the Absence and Presence of Delta9-Tetrahydrocannabinol","volume":"83","author":"Buchweitz","year":"2008","journal-title":"J Leukoc Biol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/j.sapharm.2020.03.020","article-title":"Cannabidiol as Prophylaxis for SARS-CoV-2 and COVID-19? Unfounded Claims Versus Potential Risks of Medications During the Pandemic","volume":"17","author":"Brown","year":"2021","journal-title":"Res Soc Adm Pharm"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3906\/biy-2105-73","article-title":"Cannabinoids for SARS-CoV-2 and Is There Evidence of Their Therapeutic Efficacy","volume":"45","author":"Onay","year":"2021","journal-title":"Turk J Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.631233","article-title":"The Immunopathology of COVID-19 and the Cannabis Paradigm","volume":"12","author":"Paland","year":"2021","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1159\/000510799","article-title":"Cannabinoids and COVID-19","volume":"3","author":"El Biali","year":"2020","journal-title":"Med Cannabis Cannabinoids"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.18632\/aging.202225","article-title":"In Search of Preventive Strategies: Novel High-CBD Cannabis Sativa Extracts Modulate ACE2 Expression in COVID-19 Gateway Tissues","volume":"12","author":"Wang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1038\/s41598-021-81049-2","article-title":"Cannabis Compounds Exhibit Anti-Inflammatory Activity In Vitro in COVID-19-Related Inflammation in Lung Epithelial Cells and Pro-Inflammatory Activity in Macrophages","volume":"11","author":"Anil","year":"2021","journal-title":"Sci Rep"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/life11040290","article-title":"In Vitro Evaluation of the Activity of Terpenes and Cannabidiol Against Human Coronavirus E229","volume":"11","author":"Chatow","year":"2021","journal-title":"Life (Basel)"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1089\/can.2018.0014","article-title":"The Anti-Inflammatory Properties of Terpenoids From Cannabis","volume":"3","author":"Gallily","year":"2018","journal-title":"Cannabis Cannabinoid Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/head.13345","article-title":"Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science","volume":"58","author":"Baron","year":"2018","journal-title":"Headache"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165771","article-title":"The Molecular Mechanisms That Underpin the Biological Benefits of Full-Spectrum Cannabis Extract in the Treatment of Neuropathic Pain and Inflammation","volume":"1866","author":"Maayah","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24173031","article-title":"Terpenoids and Phytocannabinoids Co-Produced in Cannabis Sativa Strains Show Specific Interaction for Cell Cytotoxic Activity","volume":"24","author":"Namdar","year":"2019","journal-title":"Molecules"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2332-7","article-title":"Proteomics of SARS-CoV-2-Infected Host Cells Reveals Therapy Targets","volume":"583","author":"Bojkova","year":"2020","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/v13030379","article-title":"In Vitro and In Vivo Models for Studying SARS-CoV-2, the Etiological Agent Responsible for COVID-19 Pandemic","volume":"13","author":"Rosa","year":"2021","journal-title":"Viruses"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1053\/j.gastro.2020.02.055","article-title":"Evidence for Gastrointestinal Infection of SARS-CoV-2","volume":"158","author":"Xiao","year":"2020","journal-title":"Gastroenterology"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1827985","article-title":"Robust and Persistent SARS-CoV-2 Infection in the Human Intestinal Brush Border Expressing Cells","volume":"9","author":"Lee","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa231","article-title":"Targeting Acute Kidney Injury in COVID-19","volume":"35","author":"Kellum","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11255-021-02976-7","article-title":"COVID-19 and the Kidney: Time to Take a Closer Look","author":"Liakopoulos","year":"2021","journal-title":"Int Urol Nephrol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/all.14498","article-title":"SARS-CoV-2, COVID-19, Skin and Immunology - What Do We Know So Far","volume":"76","author":"Novak","year":"2021","journal-title":"Allergy"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16387","article-title":"Cutaneous Manifestations in COVID-19: A First Perspective","volume":"34","author":"Recalcati","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13549","article-title":"Cutaneous Signs in COVID-19 Patients: A Review","volume":"33","author":"Wollina","year":"2020","journal-title":"Dermatol Ther"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16775","article-title":"Cutaneous Manifestations in SARS-CoV-2 Infection (COVID19): A French Experience and a Systematic Review of the Literature","volume":"34","author":"Matar","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16774","article-title":"Cutaneous Manifestations of SARS-CoV-2 Infection: A Clinical Update","volume":"34","author":"Gisondi","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.841459\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T06:53:09Z","timestamp":1644907989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.841459\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,15]]},"references-count":66,"alternative-id":["10.3389\/fimmu.2022.841459"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.841459","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,15]]},"article-number":"841459"}}